Organisation paid for research Program year 2023 Source: CMS Open Payments

Corazon USA LLC Dba

Neither a doctor nor a teaching hospital

Research payments

$769,933

8 payments

Through program year 2023, Corazon USA LLC Dba is reported as receiving $769,933 in research payments, across 8 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$500,070	3
2022	Research	$161,861	3
2021	Research	$108,002	2

Breakdown

Who paid Research payments · program years 2021–2023

Horizon Therapeutics plc $769,933 8 payments

Studies the money was for Research payments · program years 2021–2023

Infusion Duration Study to Assess Tolerability of Pegloticase Administered With A Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate $438,657 2 payments
A Phase 1B, Combined Single-Dose and Multiple-Dose, Multicenter, Randomized, Open-Label Trial to Assess Safety and Tolerability of Two Different Dose Levels of Subcutaneous Pegloticase in Subjects With Uncontrolled Gout Receiving Methotrexate $140,319 2 payments
Hznp-Kry-405 $66,828 1 payment
A Phase 4, Open-Label Study of Krystexxa (Pegloticase) Co-Administered With Methotrexate (MTX) in Patients With Uncontrolled Gout $49,794 1 payment
Hznp-Kry-407 $41,174 1 payment
A Phase 4, Multicenter, Open-Label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-Administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain A Serum Uric Acid Response $33,162 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.